Want real case studies? 10 seconds to sign up
Join the platform
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
May 30, 2026
Approximately 5 minutes
Registered Pharmacist · AI Engineer · Director, ElendiLabs
Registered pharmacist, AI engineer, HKHAIS founder, and pharmaceutical & medical device SEO/GEO specialist.
Ask Anything
We'll follow up with you personally.
100% response rate • Reply within 7 business days
Related Articles
Approximately 5 minutes
Global MedTech Compliance: A Comparative Analysis of EU-MDR and UK MHRA Frameworks (2026)
An expert synthesis of the regulatory landscape in 2026, comparing the clinical-heavy requirements of EU-MDR with the pragmatic, reliance-based pathways of the UK MHRA.
Approximately 5 minutes
Master Technical Documentation under MDR 2017/745
Technical Documentation (TD) is more than just paperwork; it is the foundation of your device's identity and proof of conformity with MDR 2017/745. This article explores the 'Iceberg' of TD, breaking down the 7 essential pillars from GSPR to Post-Market Surveillance. Learn how to apply the 3Cs—Clarity, Consistency, and Connectivity—to ensure faster Notified Body reviews and a safer time to market.
Approximately 5 minutes
EUDAMED Mandatory Timeline: Essential Insights from the Brussels Workshop
With the Commission Decision 2025/2371, EUDAMED is now officially functional. The modules for Actor, Device, and Market Surveillance become mandatory on May 28, 2026. This article outlines the critical steps for manufacturers, including EU Login setup, the strict registration order, and the distinction between the Playground and Production environments.
Approximately 5 minutes
Bridging the Gap: EU vs. US Clinical Evidence Requirements for Medical Devices
Navigating the clinical evidence requirements of the EU MDR and the US FDA often catches companies off-guard. While the EU focuses on the Clinical Evaluation Report (CER) and GSPR alignment, the FDA relies on a risk-driven approach involving PMAs and 510(k) substantial equivalence. This article explores how ISO 14155 serves as a common language for both regions and highlights common weaknesses in clinical strategies that lead to regulatory rework.
Approximately 5 minutes
EU Commission to Harmonize Notified Body Procedures: Predictability in Sight
The European Commission is developing a new implementing regulation to address the unpredictability of medical device and IVD conformity assessments. Currently, significant variations in timelines and costs among Notified Bodies cause delays that impact patient care. This new law will require Notified Bodies to publish clear review timelines, define 'clock stoppers,' and provide transparent cost breakdowns for certification and surveillance activities.
Approximately 5 minutes
Global MedTech Regulatory Compliance: A Technical Evaluation of EU MDR, CDSCO, and NMPA Pathways
A comparative technical analysis of the medical device regulatory frameworks in the European Union (EU MDR), India (CDSCO), and China (NMPA) for regulatory affairs professionals.
Approximately 5 minutes
Dual-Track Regulatory Governance: Mastering EU MDR and AI Act Compliance in European MedTech
A detailed strategic analysis examining the structural convergence of the EU Medical Device Regulation (EU MDR) and the EU Artificial Intelligence (AI) Act for Software as a Medical Device (SaMD), detailing capacity bottlenecks, data governance, and risk mitigation.